SUMATRIPTAN SUCCINATE
Generic: SUMATRIPTAN SUCCINATE
Dr. Reddy's Laboratories LimitedManufacturer
SUBCUTANEOUSRoute
SUMATRIPTAN SUCCINATEActive Substance
2014-01-29Original Approval
SUMATRIPTAN SUCCINATE is FDA application ANDA090495, sponsored by DR REDDYS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-cGMP deviations: Temperature abuse
Class II2019-12-26
Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 counFailed Impurities/Degradation Specifications; out-of-specification results obtained for related subs
Top Reported Reactions
1
DRUG INEFFECTIVE
1,147 reports
2
HEADACHE
786 reports
3
MIGRAINE
645 reports
4
NAUSEA
578 reports
5
PRODUCT DOSE OMISSION ISSUE
568 reports
6
FATIGUE
499 reports
7
OFF LABEL USE
452 reports
8
PRODUCT QUALITY ISSUE
410 reports
9
DEVICE MALFUNCTION
396 reports
10
PAIN
375 reports